ResveratrolConsumer
avert online
consumer fraud
ResveratrolQuiz
test your knowledge
New E-Book
How the world got lost on
the road to an anti-aging pill
Subscribe to our newsletter to receive email notifications when new articles are posted.
January 21, 2013: by Bill Sardi
Hartford, CT (Jan 20, 2013)- Noted red wine molecule heart researcher Dipak Das PhD has filed a $35 million defamation claim against the University of Connecticut (U CONN) Health Center for wrongful termination, violation of the university’s by-laws, and lack of due process as protected by the 14th Amendment to the United States Constitution.
Dr. Das made worldwide headlines in January of 2012 when U CONN authorities issued a press release and posted a website alleging 145 claims of scientific fraud that were backed by 60,000 pages of evidence. However, that website was quickly taken offline after many of its allegations were publicly rebutted. Soon thereafter, it came to light that the university’s review board had never read the entire report and has instead relied upon a 23-page summary in its decision to dismiss Dr. Das from his position as director of the Cardiovascular Research Center at the UCONN Health Center.
Dr. Das conducted landmark animal studies that demonstrated the red wine molecule resveratrol (rez-vair-ah-troll) can limit damage to the animal heart during a heart attack and turn a mortal heart attack into a non-mortal event.
Posted in Resveratrol ; No Comments »
January 7, 2013: by Bill Sardi
Professor Ole Vang
Resveratrol 2012
The release of your (mis)information from the RESVERATROL 2012 conclave is almost laughable. I’m laughing in my tears. Sadly, so many suffer from inability of the “resveratrol community” to come to any conclusions. How many more wasted decades before the professors can come to any agreement?
While your press statements said “there is not yet scientific evidence to recommend a general intake of resveratrol for prevention of lifestyle diseases,” and “trials in humans are necessary … to be absolutely sure of positive effects in humans,” your plea for more studies is falling on deaf ears.
Posted in Resveratrol ; No Comments »
January 3, 2013: by Bill Sardi
Report: RESVERATROL 2012 2nd International Conference of Resveratrol and Health (December 8, Leicester, England)
“Committee: a group of men who individually can do nothing, but as a group decide that nothing can be done.”
A collaborative group of scientific investigators, resveratrol raw-material manufacturers and branders of commercially available resveratrol-based products met in Leicester, England to chart the future direction for this miraculous natural molecule. The group covered a broad range of disorders that resveratrol addresses, which includes aging and cancer as well as important other issues such as optimal dosing and models for testing. Their full report can be read online here.
While the group concluded there is not unequivocal scientific data to support resveratrol for disease prevention in humans (OK for lab mice however) or human life extension (the only way to conclusively show resveratrol extends human life is to conduct a 99-year study), it did say there are encouraging preliminary results.
Posted in Resveratrol ; No Comments »
January 2, 2013: by Bill Sardi
In a free market, with an un-manipulated news media and a medical establishment open to less problematic and more economical cures, the announcement today by Dr. Stuart Richer OD, PhD, Director of Ocular Preventive Medicine at the Eye Clinic, James A Lovell Federal Health Care Center – North Chicago, would have been splashed on the front page of newspapers throughout the world.
The public would have stood in fascination at the prospect of damaged tissues in their brain, heart or eyes simultaneously repaired without invasive techniques. The idea of not having to wait decades to apply this discovery would have caused telephone lines across the world to become overloaded. But that is not the world we live in today.
Posted in Resveratrol ; No Comments »
December 31, 2012: by ResveratrolNews
North Chicago, IL (December 31, 2012) – The first report using molecular medicine to regenerate damaged tissues in the back of the human eye via use of small antioxidant molecules to promote survival of internally-produced stem cells is being reported today. It may be the first successful report of cellular or tissue regeneration via internally-derived stem cells in all of medicine.
In a newly published scientific book (Advancing Medicine With Food & Nutrients, 2nd edition, CRC Press (Ingrid Kohlstadt, editor), Dec 2012), Dr. Stuart Richer, OD, PhD, Director, Ocular Preventive Medicine- Eye Clinic at the James A Lovell Federal (Veterans) Health Care Center in North Chicago, presents striking photographic evidence of stem cell regeneration of damaged tissues at the back of the eye of a patient with dry macular degeneration accompanied by restoration of vision after using a nutriceutical comprised of small natural antioxidant molecules.
Posted in Resveratrol ; No Comments »
December 27, 2012: by Bill Sardi
For the uninitiated: resveratrol (rez-vair-ah-trol) is known as a red wine molecule that is that is believed to be chiefly, but not solely, responsible for the heart-healthy effects of red wine.
The year 2012 started out with maybe half of all resveratrol pill users abandoning their use after hearing allegations that the leading researcher in the field had committed scientific fraud. The researcher, Dipak Das PhD, working at the University of Connecticut (U CONN), was alleged to have fabricated data to gain research grant money and according to radio talk show host Rush Limbaugh, Dr. Das “made it all up” (the science that is).
While over 350 news sources covered the story, they were simply parroting allegations made by a 5-man U CONN review board, a board that concedes it never read the university’s 60,000 page evidence report and could not produce for Dr. Das’ legal counsel the original evidence disc which it said was lost. In fact, U CONN never gave Dr. Das due process and took its website offline when it was challenged to validate various facts that were egregiously inaccurate. But the damage had been done.
Posted in Resveratrol ; No Comments »
December 21, 2012: by ResveratrolNews
http://www.reuters.com/article/2012/12/20/us-ageing-hongkong-idUSBRE8BJ0B820121220
By Tan Ee Lyn
HONG KONG | Thu Dec 20, 2012 7:55am EST
(Reuters) – Scientists in Hong Kong appear to have mapped out a formula that can delay the aging process in mice, a discovery they hope to replicate in people.
Their finding, published in the December issue of Cell Metabolism, builds on their work in 2005 which shed light on premature aging, or progeria, a rare genetic disease that affects one in four million babies.
Progeria is obvious in the appearance of a child before it is a year old. Although their mental faculties are normal, they stop growing, lose body fat and suffer from wrinkled skin and hair loss. Like old people, they suffer stiff joints and a buildup of plaque in arteries which can lead to heart disease and stroke. Most die before they are 20 years old.
In that research, the team at the University of Hong Kong found that a mutation in the Lamin A protein, which lines the nucleus in human cells, disrupted the repair process in cells, thus resulting in accelerated aging.
Posted in Resveratrol ; No Comments »
December 17, 2012: by Bill Sardi
Researchers have just begun to address the idea of developing multiple-gene targeted drugs for multiple-gene targeted diseases. Single-gene targeted drugs, like Herceptin, Iressa and Erbitux have been met with disappointment. A discussion regarding the development of such drugs is published in a recently published edition of Expert Opinion in Drug Discovery.
The ability of these drugs to avoid polypharmacy (when too many forms of medication are used by a patient) is a desired secondary objective.
But in saying that, multiple-gene targeted drugs are also anathema to pharmaceutical companies that have been financially built on the false premise of one drug for each disease.
While these researchers suggest modern pharmacology switch direction and develop multi-gene targeted drugs, for now, modern medicine is dragging its feet over this idea.
Posted in Resveratrol ; No Comments »
December 9, 2012: by Bill Sardi
Stem cell technology continues to fascinate researchers and technology-driven males. Anything that is even alleged to facilitate stem cells becomes wildly popular overnight. Stem cells, if you recall, are those native unspecialized cells that can turn into heart, brain, muscle and nerve cells. Stem cells are required for tissue repair. They have great application for renewal of brain, eye and heart cells that have a very slow cell turnover rate (replace themselves only every few years!). Once damaged, these are the most difficult tissues to repair.
Matt Ridley, Wall Street Journal writer, says from the top of his recent article on this subject that “the chief medical ambition of those who study stem cells has always been that the cells would be used to repair and regenerate damaged tissue.” Well, yes, but the added requirement that any developed stem cell technology would reap a huge profit for its inventors. Of course, that might run in the wrong direction of healthcare reform, which is to find new ways to treat patients at less cost.
Posted in Resveratrol ; No Comments »
November 28, 2012: by Bill Sardi
Researchers in Berlin, Germany claim the blockage of an immune system transmitter may prevent symptoms of Alzheimer’s disease by reduction of brain plaque known as beta amyloid and suggest Alzheimer’s sufferers wait while they test an existing FDA-approved drug that may even reverse existing disease. A research study published in Nature Medicine says blockade of a gene target known as p40 was found to reduce beta amyloid brain plaque by 65% in laboratory mice. Striking hemispheric images of the brain of mice are presented at Science Daily to demonstrate the potential beneficial effect of p40 blockade.
The existing p40-blocking drug, Stelar (ustekinumab), is a monoclonal-antibody that seeks out the cell receptor for p40 and blocks accessibility of immune system activators known as interleukins. It is currently used to treat psoriasis, a chronic skin condition.
Posted in Resveratrol ; No Comments »